Archive | Featured RSS feed for this section

PPMI Study Update Call – 6/14/18

PPMI Study Update Call Cerebrospinal Fluid Analysis Thursday, June 14 12-1 pm Eastern Time Brit Mollenhauer, MD Attending Neurologist, Head of Clinical Research PPMI Steering Committee Member Paracelsus-Elena Klinik Doug Galasko, MD Professor of Neurology PPMI Steering Committee Member University of California San Diego   PPMI participants are encouraged to call in to the next […]

Continue reading...

2018 PPMI Annual Meeting Summary

The 2018 PPMI Annual Investigator’s Meeting took place on May 2-3 in New York City.  There were more than 200 attendees present, including PPMI investigators and coordinators, Industry Scientific Advisory Board representatives, The Edmond J. Safra Fellowship in Movement Disorders fellows and fellowship directors, the PPMI Patient Committee, and the PPMI Steering Committee. This meeting […]

Continue reading...

Collaboration with Verily Aims to Deepen Parkinson’s Understanding through Digital Health Tools

Wearable sensors to monitor health-related measures like heart rate, glucose levels, or physical activity are helping people assess their own health and enabling research in treating and understanding chronic disease. The Michael J. Fox Foundation (MJFF) and Verily Life Sciences LLC, an Alphabet company, are collaborating to use wearable devices — in conjunction with clinic-based data and […]

Continue reading...

PPMI Steering Committee Paper Accepted to Movement Disorders Journal

We are excited to announce a recent research article using longitudinal data from PPMI has been accepted to Movement Disorders.  Members of the PPMI Steering Committee, including Dr. Tanya Simuni of Northwestern University, authored this publication on behalf of PPMI. The study, entitled Longitudinal Change of Clinical and Biological Measures in Early Parkinson’s Disease: Parkinson’s […]

Continue reading...

PPMI Study Update Call – 3/15/18

PPMI Study Update Call Thursday, March 15 12-1 pm Eastern Time Andrew Siderowf, MD, MSCE Professor of Neurology University of Pennsylvania Co-Principal Investigator of PPMI   PPMI participants are encouraged to call in to the next quarterly Study Update Call on Thursday, March 15, 2018 at 12 pm EST.  During this call, Dr. Andrew Siderowf, […]

Continue reading...

Participant Update Call – 6/28/2017

All PPMI participants are encouraged to call in for our quarterly study update call, tomorrow at 12 pm EST. Dr. Daniel Weintraub will discuss the impact of PD on cognition. Dr. Weintraub’s talk will center around his recent publication of PPMI data in the journal PLoS One. You can read the full research article online.

Continue reading...

PPMI at MDS 2017

The 21st International Congress of Parkinson’s Disease and Movement Disorders (MDS) conference will take place next week, June 4-8, in Vancouver, Canada. PPMI leadership is happy to announce that several posters will feature PPMI data. We invite you to look for PPMI at this year’s meeting:   Blue Ribbon Highlight:  840 Multiple modality biomarker prediction […]

Continue reading...

PPMI 2017 Annual Meeting Summary

Nearly 180 PPMI investigators, coordinators, study cores, patient advisory and steering committee members, sponsors, and industry partners from around the world met in New York City May 3-4, 2017 to share PPMI study and scientific updates and to discuss the future of the initiative.  The annual meeting remains a critical component to the study. It […]

Continue reading...

PPMI iPSC Lines — A Valuable Tool for Researchers

The Parkinson?s Progression Markers Initiative (PPMI) has expanded to include the generation of induced pluripotent stem cell (iPSC) lines from reprogrammed peripheral mononuclear blood cells (PBMCs) collected from PPMI participants. Study leadership hopes to complete 135 blood collections by the end of 2017; to date, over 50 PPMI participants have given blood samples. Cells lines […]

Continue reading...

Live Webinar February 24: 2016 PPMI Data Challenge Winners

In June of 2016, The Michael J. Fox Foundation challenged data scientists and computational analysts to work with PPMI?s unprecedented collection of open-access clinical, molecular, and imaging data to answer two fundamental questions about Parkinson?s disease: what are the subtypes of the disease, and what baseline factors predict disease progression? In total, forty researchers submitted […]

Continue reading...